Structural and dynamics insights into the GBA variants associated with Parkinson’s disease

References

• Aharon-Peretz, J., Rosenbaum, H., & Gershoni-Baruch, R. (2004). Mutations in the glucocerebrosidase gene and Parkinson’s disease in Ashkenazi Jews. The New England Journal of Medicine, 351(19), 1972–1977. https://doi.org/10.1056/NEJMoa033277
   PubMed Web of Science ®Google Scholar
• Arturo-Terranova, D., Giraldo, L. J. M., & Satizábal, J. M. (2021). Research article frequency of GBA gene variants in complex disease patients in Southwestern Colombia. Genetics and Molecular Research, 20(2). https://doi.org/10.4238/gmr18818
   Web of Science ®Google Scholar
• Blanz, J., Zunke, F., Markmann, S., Damme, M., Braulke, T., Saftig, P., & Schwake, M. (2015). Mannose 6‐phosphate‐independent lysosomal sorting of LIMP‐2. Traffic, 16(10), 1127–1136. https://doi.org/10.1111/tra.12313
   PubMed Web of Science ®Google Scholar
• Brockmann, K. (2020). GBA-associated synucleinopathies: Prime candidates for alpha-synuclein targeting compounds. Frontiers in Cell and Developmental Biology, 8, 562522. https://doi.org/10.3389/fcell.2020.562522
   PubMed Web of Science ®Google Scholar
• Brockmann, K., Srulijes, K., Pflederer, S., Hauser, A.-K., Schulte, C., Maetzler, W., Gasser, T., & Berg, D. (2015). GBA-associated Parkinson’s disease: Reduced survival and more rapid progression in a prospective longitudinal study. Movement Disorders, 30(3), 407–411. https://doi.org/10.1002/mds.26071
   PubMed Web of Science ®Google Scholar
• Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999). Disruption of p53 in human cancer cells alters the responses to therapeutic agents. The Journal of Clinical Investigation, 104(3), 263–269. https://doi.org/10.1172/JCI6863
   PubMed Web of Science ®Google Scholar
• Chasman, D., & Adams, R. M. (2001). Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: Structure-based assessment of amino acid variation. Journal of Molecular Biology, 307(2), 683–706. https://doi.org/10.1006/jmbi.2001.4510
   PubMed Web of Science ®Google Scholar
• Chen, G., Fan, M., Liu, Y., Sun, B., Liu, M., Wu, J., & Guo, M. (2019). Advances in MS based strategies for probing ligand-target interactions: Focus on soft ionization mass spectrometric techniques. Frontiers in Chemistry, 7, 703.
   PubMed Web of Science ®Google Scholar
• Choi, Y., & Chan, A. P. (2015). PROVEAN web server: A tool to predict the functional effect of amino acid substitutions and Indels. Bioinformatics, 31(16), 2745–2747. https://doi.org/10.1093/bioinformatics/btv195
   PubMed Web of Science ®Google Scholar
• Cilia, R., Tunesi, S., Marotta, G., Cereda, E., Siri, C., Tesei, S., Zecchinelli, A. L., Canesi, M., Mariani, C. B., Meucci, N., Sacilotto, G., Zini, M., Barichella, M., Magnani, C., Duga, S., Asselta, R., Soldà, G., Seresini, A., Seia, M., Pezzoli, G., & Goldwurm, S. (2016). Survival and dementia in GBA‐associated Parkinson’s disease: The mutation matters. Annals of Neurology, 80(5), 662–673. https://doi.org/10.1002/ana.24777
   PubMed Web of Science ®Google Scholar
• Clark, L. N., Ross, B. M., Wang, Y., Mejia-Santana, H., Harris, J., Louis, E. D., Cote, L. J., Andrews, H., Fahn, S., Waters, C., Ford, B., Frucht, S., Ottman, R., & Marder, K. (2007). Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology, 69(12), 1270–1277. https://doi.org/10.1212/01.wnl.0000276989.17578.02
   PubMed Web of Science ®Google Scholar
• Cooper, G. M., & Shendure, J. (2011). Needles in stacks of needles: Finding disease-causal variants in a wealth of genomic data. Nature Reviews. Genetics, 12(9), 628–640. https://doi.org/10.1038/nrg3046
   PubMed Web of Science ®Google Scholar
• Davis, A. A., Andruska, K. M., Benitez, B. A., Racette, B. A., Perlmutter, J. S., & Cruchaga, C. (2016). Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression. Neurobiology of Aging, 37, 209.e201–209.e207. https://doi.org/10.1016/j.neurobiolaging.2015.09.014
   Web of Science ®Google Scholar
• Doss, C. G. P., & NagaSundaram, N. (2012). Investigating the structural impacts of I64T and P311S mutations in APE1-DNA complex: A molecular dynamics approach. PLOS One, 7(2), e31677. https://doi.org/10.1371/journal.pone.0031677
   PubMed Web of Science ®Google Scholar
• Dundas, J., Ouyang, Z., Tseng, J., Binkowski, A., Turpaz, Y., & Liang, J. (2006). CASTp: Computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Research, 34, W116–118. https://doi.org/10.1093/nar/gkl282
   PubMed Web of Science ®Google Scholar
• Gan-Or, Z., Amshalom, I., Kilarski, L. L., Bar-Shira, A., Gana-Weisz, M., Mirelman, A., Marder, K., Bressman, S., Giladi, N., & Orr-Urtreger, A. (2015). Differential effects of severe vs. mild GBA mutations on Parkinson disease. Neurology, 84(9), 880–887. https://doi.org/10.1212/wnl.0000000000001315
   PubMed Web of Science ®Google Scholar
• Gan-Or, Z., Giladi, N., Rozovski, U., Shifrin, C., Rosner, S., Gurevich, T., Bar-Shira, A., & Orr-Urtreger, A. (2008). Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. Neurology, 70(24), 2277–2283. https://doi.org/10.1212/01.wnl.0000304039.11891.29
   PubMed Web of Science ®Google Scholar
• Gotz, A. W., Williamson, M. J., Xu, D., Poole, D., Le Grand, S., & Walker, R. C. (2012). Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized born. Journal of Chemical Theory and Computation, 8(5), 1542–1555. https://doi.org/10.1021/ct200909j
   PubMed Web of Science ®Google Scholar
• Halgren, T. A. (1996). Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. Journal of Computational Chemistry, 17(5–6), 490–519. https://doi.org/10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P
   Web of Science ®Google Scholar
• Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., & Mizushima, N. (2006). Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature, 441(7095), 885–889. https://doi.org/10.1038/nature04724
   PubMed Web of Science ®Google Scholar
• Hazan, J., Fonknechten, N., Mavel, D., Paternotte, C., Samson, D., Artiguenave, F., Davoine, C. S., Cruaud, C., Dürr, A., Wincker, P., Brottier, P., Cattolico, L., Barbe, V., Burgunder, J. M., Prud’homme, J. F., Brice, A., Fontaine, B., Heilig, B., & Weissenbach, J. (1999). Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nature Genetics, 23(3), 296–303. https://doi.org/10.1038/15472
   PubMed Web of Science ®Google Scholar
• Höglinger, G., Schulte, C., Jost, W. H., Storch, A., Woitalla, D., Krüger, R., Falkenburger, B., & Brockmann, K. (2022). GBA-associated PD: Chances and obstacles for targeted treatment strategies. Journal of Neural Transmission, 129(9), 1219–1233. https://doi.org/10.1007/s00702-022-02511-7
   PubMed Web of Science ®Google Scholar
• Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., Zaslavsky, L., Zhang, J., & Bolton, E. E. (2023). PubChem 2023 update. Nucleic Acids Research, 51(D1), D1373–D1380. https://doi.org/10.1093/nar/gkac956
   PubMed Web of Science ®Google Scholar
• Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo-San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., Choi, M. E., Chu, C. T., Codogno, P., Colombo, M. I., Cuervo, A. M., Deretic, V., Dikic, I., Elazar, Z., Eskelinen, E.-L., … Pietrocola, F. (2021). Autophagy in major human diseases. The EMBO Journal, 40(19), e108863. https://doi.org/10.15252/embj.2021108863
   PubMed Web of Science ®Google Scholar
• Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J-i., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., & Tanaka, K. (2006). Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature, 441(7095), 880–884. https://doi.org/10.1038/nature04723
   PubMed Web of Science ®Google Scholar
• Kopytova, A. E., Rychkov, G. N., Nikolaev, M. A., Baydakova, G. V., Cheblokov, A. A., Senkevich, K. A., Bogdanova, D. A., Bolshakova, O. I., Miliukhina, I. V., Bezrukikh, V. A., Salogub, G. N., Sarantseva, S. V., Usenko, T. C., Zakharova, E. Y., Emelyanov, A. K., & Pchelina, S. N. (2021). Ambroxol increases glucocerebrosidase (GCase) activity and restores GCase translocation in primary patient-derived macrophages in Gaucher disease and Parkinsonism. Parkinsonism & Related Disorders, 84, 112–121. https://doi.org/10.1016/j.parkreldis.2021.02.003
   PubMed Web of Science ®Google Scholar
• Kumar, D. T., Iyer, S., Christy, J. P., Siva, R., Tayubi, I. A., Doss, C. G. P., & Zayed, H. (2019). A comparative computational approach toward pharmacological chaperones (NN-DNJ and Ambroxol) on N370S and L444P mutations causing Gaucher’s disease. Advances in Protein Chemistry and Structural Biology, 114, 315–339.
   PubMed Web of Science ®Google Scholar
• Kwon, N. H., Fox, P. L., & Kim, S. (2019). Aminoacyl-tRNA synthetases as therapeutic targets. Nature Reviews. Drug Discovery, 18(8), 629–650. https://doi.org/10.1038/s41573-019-0026-3
   PubMed Web of Science ®Google Scholar
• Li, B., Severson, E., Pignon, J.-C., Zhao, H., Li, T., Novak, J., Shen H., Aster, J. C., Rodig, S., Signoretti, S., Liu, J. S., & Liu, X. S. (2016). Comprehensive analyses of tumor immunity: Implications for cancer immunotherapy. Genome Biology, 17(1), 1–16.
   PubMedGoogle Scholar
• Lieberman, R. L., D'aquino, J. A., Ringe, D., & Petsko, G. A. (2009). Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability. Biochemistry, 48(22), 4816–4827. https://doi.org/10.1021/bi9002265
   PubMed Web of Science ®Google Scholar
• Mahmood, A., Shah, A. A., Umair, M., Wu, Y., & Khan, A. (2021). Recalling the pathology of Parkinson’s disease; lacking exact figure of prevalence and genetic evidence in Asia with an alarming outcome: A time to step‐up. Clinical Genetics, 100(6), 659–677. https://doi.org/10.1111/cge.14019
   PubMed Web of Science ®Google Scholar
• Malerba, M., & Ragnoli, B. (2008). Ambroxol in the 21st century: Pharmacological and clinical update. Expert Opinion on Drug Metabolism & Toxicology, 4(8), 1119–1129. https://doi.org/10.1517/17425255.4.8.1119
   PubMed Web of Science ®Google Scholar
• Miller, B. R., III, McGee, T. D., Jr., Swails, J. M., Homeyer, N., Gohlke, H., & Roitberg, A. E. (2012). MMPBSA.py: An efficient program for end-state free energy calculations. Journal of Chemical Theory and Computation, 8(9), 3314–3321. https://doi.org/10.1021/ct300418h
   PubMed Web of Science ®Google Scholar
• Moberly, J. G., Bernards, M. T., & Waynant, K. V. (2018). Key features and updates for origin 2018. Journal of Cheminformatics, 10(1), 5. https://doi.org/10.1186/s13321-018-0259-x
   PubMedGoogle Scholar
• Naïm, M., Bhat, S., Rankin, K. N., Dennis, S., Chowdhury, S. F., Siddiqi, I., Drabik, P., Sulea, T., Bayly, C. I., Jakalian, A., & Purisima, E. O. (2007). Solvated interaction energy (SIE) for scoring protein − ligand binding affinities. 1. Exploring the parameter space. Journal of Chemical Information and Modeling, 47(1), 122–133. https://doi.org/10.1021/ci600406v
   PubMed Web of Science ®Google Scholar
• Pradas, E., & Martinez-Vicente, M. (2023). The consequences of GBA deficiency in the autophagy–Lysosome system in Parkinson’s disease associated with the GBA. Cells, 12(1), 191. https://doi.org/10.3390/cells12010191
   PubMed Web of Science ®Google Scholar
• Reynolds, C. H., & Holloway, M. K. (2011). Thermodynamics of ligand binding and efficiency. ACS Medicinal Chemistry Letters, 2(6), 433–437. https://doi.org/10.1021/ml200010k
   PubMed Web of Science ®Google Scholar
• Rodríguez-Casado, A. (2012). In silico investigation of functional nsSNPs – an approach to rational drug design. Research and Reports in Medicinal Chemistry, 31–42.
   Google Scholar
• Roe, D. R., & Cheatham, T. E. III (2013). PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation, 9(7), 3084–3095. https://doi.org/10.1021/ct400341p
   PubMed Web of Science ®Google Scholar
• Salomon-Ferrer, R., Case, D. A., & Walker, R. C. (2013). An overview of the Amber biomolecular simulation package. Wiley Interdisciplinary Reviews, 3(2), 198–210. https://doi.org/10.1002/wcms.1121
   Google Scholar
• Samad, A., Ajmal, A., Mahmood, A., Khurshid, B., Li, P., Jan, S. M., Rehman, A. U., He, P., Abdalla, A. N., Umair, M., Hu, J., & Wadood, A. (2023). Identification of novel inhibitors for SARS-CoV-2 as therapeutic options using machine learning-based virtual screening, molecular docking and MD simulation. Frontiers in Molecular Biosciences, 10. https://doi.org/10.3389/fmolb.2023.1060076
   PubMed Web of Science ®Google Scholar
• Schwarz, J. M., Cooper, D. N., Schuelke, M., & Seelow, D. (2014). MutationTaster2: Mutation prediction for the deep-sequencing age. Nature Methods, 11(4), 361–362. https://doi.org/10.1038/nmeth.2890
   PubMed Web of Science ®Google Scholar
• Shah, A. A., Amjad, M., Hassan, J.-U., Ullah, A., Mahmood, A., Deng, H., Ali, Y., Gul, F., & Xia, K. (2022). Molecular insights into the role of pathogenic nsSNPs in GRIN2B gene provoking neurodevelopmental disorders. Genes, 13(8), 1332. https://doi.org/10.3390/genes13081332
   PubMed Web of Science ®Google Scholar
• Shastry, B. S. (2009). SNPs: Impact on gene function and phenotype. Methods in Molecular Biology, 578, 3–22. https://doi.org/10.1007/978-1-60327-411-1_1
   PubMedGoogle Scholar
• Straniero, L., Rimoldi, V., Monfrini, E., Bonvegna, S., Melistaccio, G., Lake, J., Soldà, G., Aureli, M., Keagle, P., Foroud, T., Landers, J. E, Blauwendraat, C., Zecchinelli, A., Cilia, R., Di Fonzo, A., Pezzoli, G., Duga, S., Asselta, R., Shankaracharya, S. (2022). Role of lysosomal gene variants in modulating GBA‐associated Parkinson’s disease risk. Movement Disorders, 37(6), 1202–1210. https://doi.org/10.1002/mds.28987
   PubMed Web of Science ®Google Scholar
• Swan, M., & Saunders-Pullman, R. (2013). The association between ss-glucocerebrosidase mutations and Parkinsonism. Current Neurology and Neuroscience Reports, 13(8), 1–10. https://doi.org/10.1007/s11910-013-0368-x
   Web of Science ®Google Scholar
• Tayebi, N., Walker, J., Stubblefield, B., Orvisky, E., LaMarca, M. E., Wong, K., Rosenbaum, H., Schiffmann, R., Bembi, B., & Sidransky, E. (2003). Gaucher disease with Parkinsonian manifestations: Does glucocerebrosidase deficiency contribute to a vulnerability to Parkinsonism? Molecular Genetics and Metabolism, 79(2), 104–109. https://doi.org/10.1016/S1096-7192(03)00071-4
   PubMed Web of Science ®Google Scholar
• Ullah, A., Shah, A. A., Syed, F., Mahmood, A., Ur Rehman, H., Khurshid, B., Samad, A., Ahmad, W., & Basit, S. (2023). Molecular dynamic simulation analysis of a novel missense variant in CYB5R3 gene in patients with methemoglobinemia. Medicina, 59(2), 379. https://doi.org/10.3390/medicina59020379
   PubMedGoogle Scholar
• Wang, Q., Mehmood, A., Wang, H., Xu, Q., Xiong, Y., & Wei, D.-Q J. M. (2019). Computational screening and analysis of lung cancer related non-synonymous single nucleotide polymorphisms on the human Kirsten rat sarcoma gene. Molecules, 24(10), 1951.https://doi.org/10.3390/molecules24101951
   PubMed Web of Science ®Google Scholar
• Zunke, F., Andresen, L., Wesseler, S., Groth, J., Arnold, P., Rothaug, M., Mazzulli, J. R., Krainc, D., Blanz, J., Saftig, P., & Schwake, M. (2016). Characterization of the complex formed by β-glucocerebrosidase and the lysosomal integral membrane protein type-2. Proceedings of the National Academy of Sciences of the United States of America, 113(14), 3791–3796. https://doi.org/10.1073/pnas.1514005113
   PubMed Web of Science ®Google Scholar